ProPhase LabsPRPH 
$0.684.62%24h
4.62%24h
Global rank30376
Market cap$12.27M
Change 7d-2.86%
YTD Performance-84.89%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of ProPhase Labs (PRPH)
As of December 2024, ProPhase Labs has a market cap of $12.27M. This makes ProPhase Labs the world's 30376th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of ProPhase Labs from 1994 to 2024
-
Value:-
Market cap history of ProPhase Labs from 1994 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $89.41M | 9.62% |
| 2023 | $81.56M | -53.06% |
| 2022 | $173.77M | 34.31% |
| 2021 | $129.38M | -21.90% |
| 2020 | $165.65M | 365.99% |
| 2019 | $35.55M | -37.46% |
| 2018 | $56.84M | 45.16% |
| 2017 | $39.16M | 8.50% |
| 2016 | $36.09M | 33.33% |
| 2015 | $27.07M | 2.74% |
| 2014 | $26.35M | -9.32% |
| 2013 | $29.05M | 18.38% |
| 2012 | $24.54M | 18.26% |
| 2011 | $20.75M | -4.17% |
| 2010 | $21.65M | -38.78% |
| 2009 | $35.37M | -51.00% |
| 2008 | $72.18M | -16.14% |
| 2007 | $86.07M | -16.17% |
| 2006 | $102.68M | -58.83% |
| 2005 | $249.38M | 63.94% |
| 2004 | $152.12M | -20.77% |
| 2003 | $192.00M | 93.45% |
| 2002 | $99.25M | 139.13% |
| 2001 | $41.50M | 183.08% |
| 2000 | $14.66M | -49.02% |
| 1999 | $28.76M | -71.19% |
| 1998 | $99.81M | -61.69% |
| 1997 | $260.52M | 65.59% |
| 1996 | $157.33M | 13850.00% |
| 1995 | $1.13M | -19.99% |
| 1994 | $1.41M | - |
PRPH Market Cap Today is $12.27M 4.62% - 14 Dec 2024
View largest stocks by market cap 
